Endometriosis and ovarian cancer

被引:24
|
作者
Kralickova, Milena [1 ,2 ,3 ]
Vetvicka, Vaclav [4 ]
机构
[1] Charles Univ Prague, Fac Med, Dept Histol & Embryol, CZ-30100 Plzen, Czech Republic
[2] Charles Univ Prague, Fac Med, Univ Hosp, Dept Obstet & Gynecol, CZ-30166 Plzen, Czech Republic
[3] Charles Univ Prague, Fac Med Plzen, Biomed Ctr, CZ-30166 Plzen, Czech Republic
[4] Univ Louisville, Dept Pathol, Louisville, KY 40202 USA
来源
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 5卷 / 05期
关键词
Endometriosis; Ovarian cancer; Biomarkers; Cancer; Histology;
D O I
10.5306/wjco.v5.i5.800
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometriosis is the leading cause of morbidity among premenopausal women and the complex pathogenesis of this disease remains controversial despite extensive research. This disease represents one of the most common gynecological problems. It is generally believed that this disease is due primarily to retrograde menstruation or transplantation of shed endometrium. Based on overwhelming data, ovarian endometrioma is considered a neoplastic process, since most endometriosis-associated ovarian carcinoma occur in the presence of atypical ovarian endometriosis. A study comparing patients with typical epithelial ovarian cancer with endometriosis-associated ovarian cancer demonstrated that the patients with the latter disease strongly differ in both biological and histological characteristics. The prevelance of this disease is not completely established, but approximately 15 percent of women suffer from this disease. In addition, we know about the possible links between endometriosis and cancer for almost 100 years. Despite clear evidence revealing that endometriosis increases ovarian cancer risks, it is possible that it may not affect disease progression after the appearance of ovarian cancer. However, despite clear evidence revealing that endometriosis increases ovarian cancer risk, our knowledge of the risk factors is far from established. In our review, we focused on the most recent approaches including possible biomarkers and genetic approaches. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 50 条
  • [1] Ovarian cancer and endometriosis
    Eulalia Fernandez, Ma
    Ponce, Jordi
    Garcia-Tejedor, Amparo
    Jesus Pla, Ma
    Fernandez de Castillo, Luis
    Gine, Luis
    [J]. GINECOLOGIA Y OBSTETRICIA CLINICA, 2011, 12 (02): : 114 - U2
  • [2] Endometriosis and ovarian cancer
    Vercellini, Paolo
    Somigliana, Edgardo
    Buggio, Laura
    Bolis, Giorgio
    Fedele, Luigi
    [J]. LANCET ONCOLOGY, 2012, 13 (05): : E188 - E189
  • [3] Ovarian cancer in endometriosis
    Konishi, Ikuo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 377 - 377
  • [4] Ovarian cancer in endometriosis
    Ikuo Konishi
    [J]. International Journal of Clinical Oncology, 2009, 14 : 377 - 377
  • [5] Ovarian cancer and endometriosis.
    Modugno, F
    Ness, R
    Allen, G
    Schildkraut, J
    Davis, F
    Goodman, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 332 - 332
  • [6] Endometriosis and ovarian cancer: A review
    Vlahos, Nikos F.
    Kalampokas, Theodoros
    Fotiou, Stylianos
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (03) : 213 - 219
  • [7] ENDOMETRIOSIS AND THE RISK FOR OVARIAN CANCER
    Trifan, C. N.
    Pasat, S.
    Hutanu, D.
    Tirnovanu, S. D.
    Mucilenita, C.
    Tirnovanu, M. C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A149 - A149
  • [8] Prevalence of endometriosis in ovarian cancer
    Yoshikawa, H
    Jimbo, H
    Okada, S
    Matsumoto, K
    Onda, T
    Yasugi, T
    Taketani, Y
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 : 11 - 15
  • [9] ENDOMETRIOSIS AND OVARIAN-CANCER
    VERCELLINI, P
    PARAZZINI, F
    BOLIS, G
    CARINELLI, S
    DINDELLI, M
    VENDOLA, N
    LUCHINI, L
    CROSIGNANI, PG
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (01) : 181 - 182
  • [10] Endometriosis and ovarian cancer reply
    Pearce, Celeste Leigh
    Berchuck, Andrew
    [J]. LANCET ONCOLOGY, 2012, 13 (05): : E190 - E190